AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

HealthTrust Addresses Drug Shortages by Supporting Member Access to Essential Medicines

November 18, 2019 GMT

NASHVILLE, Tenn.--(BUSINESS WIRE)--Nov 18, 2019--

HealthTrust announced today it has added two more mission-critical drugs – Diprivan® and heparin – to its proprietary pharmacy-contracting model, which is designed to help ease the impact of supply interruptions of essential medications for member hospitals. Under a new agreement with Fresenius Kabi, DIPRIVAN® (propofol) and heparin will be contracted through the HealthTrust Supply Interruption Mitigation Strategies (SIMS), a healthcare improvement program targeting more than 75 medications identified by providers and clinical advisory boards as critical to patient care.

“Our rigor creates supply confidence for HealthTrust members for these essential medicines,” said Vincent Jackson, vice president of HealthTrust’s Pharmacy Services Group.

HealthTrust is working with Fresenius Kabi and other manufacturers that demonstrate the capabilities necessary to meet the strict criteria for SIMS inclusion. HealthTrust expects to contract 15 SIMS products by the end of 2019.

“Our purpose is to put lifesaving medicines in the hands of caregivers, and we are pleased to work with HealthTrust to help address the challenges drug shortages create for hospitals,” said Scott Meacham, president, pharmaceuticals and devices, Fresenius Kabi USA.

DIPRIVAN® (propofol) is a cornerstone of anesthesia care. Heparin is one of the most widely used injectable anticoagulants with multiple therapeutic indications. Suppliers of SIMS products undergo a rigorous vetting centered on supply chain viability and sustainability. In return for scale, predictable purchasing volumes and sustainable pricing, drug makers commit to manufacturing redundancies, and firm prices—important factors that can help insulate members from drug shortages.

About HealthTrust

HealthTrust (Healthtrust Purchasing Group, L.P.) is committed to strengthening provider performance and clinical excellence through an aligned membership model and the delivery of total spend management advisory solutions that leverage operator experience, scale and innovation. Headquartered in Nashville, Tenn., HealthTrust ( www.healthtrustpg.com ) serves over 1,600 hospitals and health systems, and more than 43,000 other member locations including ambulatory surgery centers, physician practices, long-term care and alternate care sites. On Twitter @healthtrustpg.

For the original version of this release visit: https://healthtrustpg.com/press/

View source version on businesswire.com:https://www.businesswire.com/news/home/20191118005610/en/

CONTACT: Richard Jonardi

richard.jonardi@healthtrustpg.com

615.344.3219

KEYWORD: TENNESSEE UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HOSPITALS PHARMACEUTICAL HEALTH MEDICAL SUPPLIES

SOURCE: HealthTrust

Copyright Business Wire 2019.

PUB: 11/18/2019 11:04 AM/DISC: 11/18/2019 11:04 AM

http://www.businesswire.com/news/home/20191118005610/en